This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Surgery, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Maria A. Kouvaraki, MD,PhD; Jeffrey E. Lee, MD; Suzanne E. Shapiro, MS; Robert F. Gagel, MD; Steven I. Sherman, MD; Rena V. Sellin, MD; Gilbert J. Cote, PhD; Douglas B. Evans, MD

Arch Surg. 2002;137:641-647.

Hypothesis  Multiple endocrine neoplasia type 1 (MEN 1) syndrome is an autosomal dominant disorder caused by germline mutations in the MEN1 gene and characterized by multiple endocrine tumors, most notably in the parathyroid glands, pituitary, and pancreas. The syndrome demonstrates variable expressivity and considerable genetic heterogeneity. Patient data were examined for possible associations between genotype and phenotype.

Design  We reviewed recorded medical data from 1975 to 2001 on patients with MEN 1 and compared specific types and locations of MEN1 gene mutations with manifestations of the syndrome.

Patients and Results  We identified 109 affected patients from 24 MEN 1 kindreds. The phenotypic expression of MEN 1 in affected individuals included hyperparathyroidism in 74%, pancreatic endocrine tumors in 51%, and pituitary tumors in 35%. Twelve of 14 insulinomas occurred in patients with pituitary tumors. Mutation analysis was completed in 14 of 24 kindreds (80 of the 109 patients). Mutations were most common in exons 2 (31%), 9 (15%), and 10 (23%). All 21 patients with frameshift mutations (and known pancreatic endocrine tumor status) had such tumors. Pituitary tumors were associated with frameshift mutations in exon 2.

Conclusions  The type and location of MEN1 mutations may be associated with the phenotypic expression of specific tumors. Such information may assist in the genetic counseling and surveillance of at-risk patients. A specific genotype-phenotype correlation is unlikely because of the heterogeneity of the mutations in the MEN1 gene.

From the Departments of Surgical Oncology (Drs Kouvaraki, Lee, and Evans and Ms Shapiro) and Endocrine Neoplasia and Hormonal Disorders (Drs Gagel, Sherman, Sellin, and Cote), The University of Texas MD Anderson Cancer Center, Houston.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile
Lourenco et al.
Eur J Endocrinol 2008;159:259-274.
ABSTRACT | FULL TEXT  

MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1
Jiang et al.
Endocr Relat Cancer 2007;14:1073-1079.
ABSTRACT | FULL TEXT  

Multiple Endocrine Neoplasia Type-I-like Syndrome in Two Cats
Roccabianca et al.
Vet Pathol 2006;43:345-352.
ABSTRACT | FULL TEXT  

Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease
Dreijerink et al.
Eur J Endocrinol 2005;153:741-746.
ABSTRACT | FULL TEXT  

Surgical Treatment of Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 1
Lambert et al.
Arch Surg 2005;140:374-382.
ABSTRACT | FULL TEXT  

Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1
Asgharian et al.
J. Clin. Endocrinol. Metab. 2004;89:5328-5336.
ABSTRACT | FULL TEXT  

Multiple Endocrine Neoplasia Type 1 Variant with Frequent Prolactinoma and Rare Gastrinoma
Hao et al.
J. Clin. Endocrinol. Metab. 2004;89:3776-3784.
ABSTRACT | FULL TEXT